Sort
38,696 grants matching “als”
Training Therapists to Administer Contingency Management
$352,926Nancy M Petry · University Of Connecticut Sch Of Med/Dnt · R01 · FY2006 · DA
Research Project 2
$352,888Paul F Worley · Johns Hopkins University · P50 · FY2016 · DA
Infrared Spectroscopy of Melts: New Approaches to Understanding Lava Flow Emplacement
$352,847Michael S Ramsey · University Of Pittsburgh · · FY2010 · GEO
Mechanisms of cross talk between insulin and adiponectin signaling pathways
$352,836Lily Q. Dong · University Of Texas Hlth Science Center · R01 · FY2010 · DK
Targeting Lymphatic Vessels for Ligand Directed Imaging
$352,801Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
THERAPEUTIC BENEFIT OF HYDROGEN PEROXIDE REMOVAL IN FALS
$352,750Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · NS
THERAPEUTIC BENEFIT OF HYDROGEN PEROXIDE REMOVAL IN FALS
$352,750Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · NS
THERAPEUTIC BENEFIT OF HYDROGEN PEROXIDE REMOVAL IN FALS
$352,750Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · NS
Human Measurement Core (HMC)
$352,727Richard N. Bergman · University Of Southern California · U54 · FY2009 · CA
GENETIC CONTROL OF SKELETAL PATTERNING AND DEVELOPMENT
$352,670Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · AR
Characterization of KIFAP3, a Modifier of Survival in Sporadic ALS
$352,647John E. Landers · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · NS
Investigation of post-translational modifications in WT SOD1 in sporadic ALS
$352,647Daryl A Bosco · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · NS
Investigation of post-translational modifications in WT SOD1 in sporadic ALS
$352,647Daryl A Bosco · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · NS
Characterization of KIFAP3, a Modifier of Survival in Sporadic ALS
$352,647John E. Landers · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · NS
Mechanisms of cross talk between insulin and adiponectin signaling pathways
$352,639Lily Q. Dong · University Of Texas Hlth Science Center · R01 · FY2012 · DK
Project 3: Maternal Exposure to Environmental Hazards and Psychosocial Stressors and Postpartum Allostatic Load
$352,635Rima Habre · University Of Southern California · P50 · FY2020 · MD
Neuromuscular Activity: Development and Survival of Avian and Mammalian Neurons
$352,604Ronald W Oppenheim · Wake Forest University Health Sciences · R01 · FY2009 · NS
Defining Residues Critical To Fibrin Clot Structure
$352,579University Of North Carolina Chapel Hill · R01 · FY2004 · HL
Treating AT deficiency with drugs that modulate the proteoatasis network
$352,533David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2015 · DK
Characterization and Treatment of the Scarred Vocal Fold
$352,497Diane M Bless · University Of Wisconsin-Madison · R01 · FY2008 · DC
Phase III infliximab for primary treatment of Kawasaki disease IND 11046 6/27/200
$352,480Jane C Burns · University Of California, San Diego · R01 · FY2010 · FD
Imaging of Hydroxyapatite as an Early Screen for Age-Related Macular Degeneration
$352,468Richard Blair Thompson · University Of Maryland Baltimore · R01 · FY2022 · EY
Treatment of ALS based on transplantation of glial restricted progenitors
$352,444Piotr Walczak · Johns Hopkins University · R01 · FY2017 · NS
Protein Characterization By Mass Spectrometry
$352,417Kenneth Tomer · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Statistical, population genetics and genetic epidemiology
$352,415Dmitri V Zaykin · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES